Piotr Seweryn Gniadek
Chief Executive Officer at GARIN S.A.
Profile
Piotr Seweryn Gniadek is currently the Chairman-Management Board at Garin SA since 2017 and at Gero SA since 2010.
He previously held positions such as Chairman, President & Chief Executive Officer at Motoricus SA, and Member-Supervisory Board at Erne Ventures SA, Hemp & Health SA, The Farm 51 Group SA, and Neurone Studio SA. Mr. Gniadek has an undergraduate degree from the Polish Japanese Institute of Information Technology and a graduate degree from Wyzsza Szkola Marketingu I Zarzadzania.
Piotr Seweryn Gniadek active positions
| Companies | Position | Start |
|---|---|---|
| GARIN S.A. | Chief Executive Officer | 30/12/2017 |
| Gero SA | Chief Executive Officer | 31/12/2009 |
Former positions of Piotr Seweryn Gniadek
| Companies | Position | End |
|---|---|---|
| HEMP & HEALTH S.A. | Director/Board Member | - |
| NEURONE STUDIO S.A. | Director/Board Member | - |
| ERNE VENTURES SA | Director/Board Member | - |
| THE FARM 51 GROUP SPÓLKA AKCYJNA | Director/Board Member | - |
| MOTORICUS SPÓLKA AKCYJNA | Chief Executive Officer | - |
Training of Piotr Seweryn Gniadek
| Polish Japanese Institute of Information Technology | Undergraduate Degree |
| Wyzsza Szkola Marketingu I Zarzadzania | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| HEMP & HEALTH S.A. | Commercial Services |
| GARIN S.A. | Consumer Durables |
| THE FARM 51 GROUP SPÓLKA AKCYJNA | Consumer Durables |
| NEURONE STUDIO S.A. | Technology Services |
| Private companies | 3 |
|---|---|
Erne Ventures SA
 Erne Ventures SA Specialty StoresRetail Trade Erne Ventures SA is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; RX-5902 or Supinoxin for metastatic triple negative breast cancer; and RX-0201 or Archexin for renal cell carcinoma, glioblastoma, ovarian, stomach, and pancreatic cancer. It also develops nano-based drug delivery systems. The company was founded by Arkadiusz Stefan Kuich in September 2007 and is headquartered in Warszawa, Poland. | Retail Trade |
Motoricus SA
 Motoricus SA Wholesale DistributorsDistribution Services Motoricus SA engages in the sale of automotive accessories and provision of marketing services. It distributes car parts online and operates repair shops. The firm also owns marketing agency offering e-commerce, e-marketing, and e-public relations services. The company was founded on October 3, 2008 and is headquartered in Warsaw, Poland. | Distribution Services |
| Gero SA |
- Stock Market
- Insiders
- Piotr Seweryn Gniadek
